🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with blood pressure reduction mechanisms on glp-1? Page 7

Has anyone dealt with blood pressure reduction mechanisms on glp-1?

ZaraB_AL Mon, Jul 22, 2024 at 12:53 PM 53 replies 2,492 viewsPage 7 of 11
PurityPaulOR
Senior Member
1,890
7,890
Mar 2024
Oregon
Aug 10, 2024 at 9:43 PM#31
claudia_zurich said:
Metabolic syndrome resolution on cardiovascular risk: I went from meeting 4 of 5 diagnostic criteria to meeting ZERO after 12 months of treatment.

Adding the part of the answer the thread has not reached. The mechanism is more central than most summaries suggest. Receptor agonism in the arcuate nucleus activates POMC neurons and inhibits AgRP/NPY signalling, and the downstream MC4R pathway is the same one disrupted in monogenic obesity — convergent genetic evidence that the target is the right one. Peripherally there is glucose-dependent insulin secretion, glucagon suppression and delayed gastric emptying, but the gastric component largely adapts over months while the central effect persists, which is why the durable effect is appetite rather than fullness.

Happy to go further on any of that.

Last edited: Aug 11, 2024 at 12:43 AM
31 4Dr.LeslieOBGYN, MikeNYC_runner and 28 others
Reply Quote Save Share Report
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Aug 12, 2024 at 5:29 AM#32
claudia_zurich said:
Metabolic syndrome resolution on cardiovascular risk: I went from meeting 4 of 5 diagnostic criteria to meeting ZERO after 12 months of treatment.

6 month update on cardiovascular risk: down 47 lbs, off blood pressure meds, A1C normalized. Genuinely life-changing.

32 5KristenIndy, MarkLI_maint, Dr.PeteFamMed and 29 others
Reply Quote Save Share Report
DadBodDave
Member
187
923
Nov 2024
Ohio
Aug 13, 2024 at 1:15 PM#33

A narrower follow-up, since the general answer is now clear:

What would you measure differently if you were starting again?

Last edited: Aug 13, 2024 at 4:15 PM
33 6pat_auckland, Dr.GastroMayo, JakeBK_lifts and 30 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
DebRD_ATL
Senior Member
1,678
7,890
Feb 2024
Atlanta, GA
Aug 14, 2024 at 9:00 PM#34
VendorMark said:
6 month update on cardiovascular risk: down 47 lbs, off blood pressure meds, A1C normalized.

Dizziness and cardiovascular risk: I was lightheaded for the first 2 weeks. Root cause was a combination of reduced caloric intake and mild dehydration.

Fix: minimum 80-100oz water daily, don't skip meals even if you're not hungry (eat small protein-rich snacks), and stand up slowly from sitting/lying positions. Also check your blood pressure — GLP-1-induced weight loss can make BP meds too strong, requiring dose reduction.

34 7PedsEndoPhilly, SleepDoc_PDX, RegAffairsDC and 31 others
Reply Quote Save Share Report
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Aug 16, 2024 at 4:44 AM#35
VendorMark said:
6 month update on cardiovascular risk: down 47 lbs, off blood pressure meds, A1C normalized.

Positive "side effect" of cardiovascular risk: my blood pressure dropped so much that I'm now off metoprolol entirely! My cardiologist is thrilled.

If you're on BP meds and losing weight on a GLP-1, monitor your BP at home regularly. Hypotension symptoms (dizziness, lightheadedness when standing) mean your BP meds may need reduction. Don't wait for your next scheduled appointment — call your doctor.

35 8emily_PDX, Dr.SleepRoch, laura_annarbor and 32 others
Reply Quote Save Share Report
15678911

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register